SCNI
Scinai Immunotherapeutics Ltd.
stockNASDAQADR
At CloseOct 22, 2026 3:53:33 PM EDT
0.59USD-3.310%(-0.02)137,844
Pre-marketOct 22, 2026 9:17:30 AM EDT
0.5701USD-6.572%(-0.0401)
After-hoursOct 22, 2026 4:53:30 PM EDT
0.568USD-3.729%(-0.022)
Loading…
Loading…
798,405
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Po Box 4143 14 Einstein Street, Ness Ziona, Israel
Previous Close
$0.61
Beta
1.86
52-Week High
$15.50 2025-11-03
52-Week Low
$0.55 2026-10-21
SMA 50
$1.77
SMA 200
$4.69
Avg. Vol 10D
6.81M
Avg. Vol 30D
4.44M
Avg. Vol 90D
1.54M
Relative Vol
0.03
1.35M
87
0.01%
19,900
22873.56%
1.00
50%/50%
74.39%
69.58%
357.6700%
100,000
100
32,558
271,050
Nov 23, 2026 (31d)
Aug 21, 2026 · 1-for-10 (reverse)
-6.8M
-0.77
-9.5M
Oct 16, 2026
Oct 14, 2026
Sep 21, 2026
Scinai regains Nasdaq minimum bid price compliance; shares up · 
Seeking Alpha
SCNI Profile
biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax's technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.
SCNI Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.75 | 2026-10-16 | -21.58% | -4.243 |
| 1M | 1.98 | 2026-09-23 | -70.20% | 3.595 |
| 3M | 2.47 | 2026-07-23 | -76.12% | 0.715 |
| 6M | 4.56 | 2026-04-23 | -87.06% | 2.006 |
| 1Y | 14.20 | 2025-10-23 | -95.84% | 1.863 |
| 2Y | 38.40 | 2024-10-23 | -98.46% | — |
| 5Y | 132.98 | 2023-09-07 | -99.56% | 0.953 |
SCNI Stock Summary
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) stock price today is $0.59, and today's volume is 137,844. SCNI is down 3.310% today. The 30 day average volume is 4.44M. SCNI market cap is $798,405 with 1.35M shares outstanding.